What's breaking now, across thousands of outlets.
(MedPage Today) -- One-year results from the open-label extension of the phase III MINT trial presented at the American Association of Neuromuscular and Electrodiagnostic Medicine annual meeting showed that the benefits of inebilizumab (Uplizna...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
A respected figure in the world of global health, Dr. Kerry takes on a new responsibility. She says it's challenging but not "daunting."
Despite what some analysts described as low expectations, RAP-219 narrowly hit the main goal of a mid-stage study, results that could help it tap a billion-dollar-plus market opportunity.
Leptospirosis can initially resemble common monsoon illnesses, but without timely diagnosis and treatment, it can progress to life-threatening complications affecting the kidneys, liver and lungs
The experts used 3D models to uncover how cancer cells responded when mechanically confined for prolonged periods of time.
The US has raised its Kenya travel advisory to level three, urging citizens to reconsider trips amid an Ebola outbreak and nine confirmed cases.
